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Introduction
GHMP kinase family of enzymes (named from some of the enzymes originally assigned to the family: galactokinase, homoserine kinase, mevalonate kinase and phosphomevalonate kinase) [42, 43] .
While the majority of these enzymes have an aspartate (or glutamate) residue in a structurally equivalent position to the putative active site base in galactokinase, at least one member does not.
In homoserine kinase (EC 2.7.1.39) the equivalent residue is an asparagine, a residue which lacks the capacity to act as a base in this manner [44, 45] . It has been proposed, based on crystal structures and enzyme kinetic analysis, that homoserine kinase catalyzes the reaction partly by stabilizing the transition state [44] . It is possible that, in this enzyme, negatively charged oxygens on the γphosphate of ATP abstract the proton from homoserine facilitating a direct transfer of the phosphate group [2] . Furthermore, in order to act as a base capable of removing a proton from the monosaccharide, the aspartate in galactokinase would need a pK a value considerably higher than that of the free amino acid (4.8 [46] ) or the pK a of the C 1 -OH would need to be substantially reduced.
Such alterations are possible in the interior of proteins. However, previous computational chemistry work suggests that the pK a of this active site aspartate (Asp-186) in human galactokinase is 5.3-6.3 [47] . While this is displaced from the free solution value, it may not be sufficient to facilitate transfer of the proton. Nevertheless, a number of studies have demonstrated that this aspartate is critical for the function of galactokinase from a variety of species [16, 40, 47, 48] . In addition, an adjacent arginine residue (Arg-37 in human galactokinase) is also believed to be important and may play a role in modifying the pK a of the aspartate or stabilising the negative charge that develops on the sugar as it loses the proton [40] . Experiments in which active site residues are altered using site-directed mutagenesis are always compounded by the possibility that they may also cause alterations to the protein's structure or stability. In the case of Asp-186 in human galactokinase, alteration to either asparagine or alanine decreased the protein's resistance to denaturation by urea [47] . Therefore, it is difficult to deduce that the loss of enzyme activity resulting from these alterations is caused entirely by the loss of chemical functionality at the active site.
In an attempt to resolve some of these mechanistic issues, we previously conducted a detailed quantum mechanics/molecular mechanics (QM-MM) study of galactokinase [49] . This predicted that Asp-186 does not, directly, participate in the reaction and that there is direct transfer of the phosphate group from ATP to galactose. Its role may be to polarise and weaken the oxygenhydrogen bond in C 1 -OH facilitating the direct attack by ATP [47, 49] . This study also identified a number of other residues which may play a key role in the enzyme's mechanism. Arg-105 and Glu-174 were predicted to cooperate in the formation of a hydrogen bonding network which restricts the mobility of ATP in the active site. Arg-228 may stabilise the transient negative charge which develops on the oxygen bridging the β-and γ-phosphates of ATP during bind breakage [49] .
A greater understanding of this enzyme's mechanism is important for the development of selective inhibitors of galactokinase and the fully exploiting its potential as a biocatalyst. Catalytically important residues could be sterically hindered or modified by drug-like molecules. The dynamic behaviour of enzymes is critical to their functions, including specificity and catalysis [50, 51] .
Knowing the structural and dynamic requirements for catalysis may enable further engineering of the enzyme's specificity. Therefore, we conducted a combined molecular dynamics (MD) and enzymological study to further elucidate the roles of Arg-105, Glu-174 and Arg-228.
Materials and Methods

Molecular dynamics simulations
Protein Preparation and Molecular dynamics simulations were carried out as described by Huang et al, 2013 [49] . Chain A of the GALK crystal structure (1WUU) was altered using Biovia Discovery studio (Dassault Systèmes), Ser230 and Leu231 were added, selenomethionine residues were varied back to native methionine, AMP.PNP was altered to ATP and Mg 2+ and the two coordinating water molecules were added to the active site. Variants were produced using the mutate feature in Biovia Discovery studio. Partial and RESP charges of galactose, Mg 2+ and ATP were determined as previously described using the Gaussian 09 package [52] and antechamber encoded in Amber 10 [53] respectively. All MD simulations were carried out using the Amber 10 package and the Amber Parm 99 forcefields [54] .
Prior to simulation the protein, ATP and galactose were soaked in a TIP3P water box using tleap encoded in Amber 10. The dimensions of the box for all proteins were 71.071 Å X 80.431 Å X 87.517 Å and the minimum distance to the boundary of the protein was set to 8 Å. Sodium ions were added to neutralise the system WT. E174D, R37K and R228K required seven ions, E174Q, D186A and D186N required 6 ions, both R105M and R228M required eight ions and R37E required nine. Minimisation and simulation steps were carried out as described by Huang et al [49] . The system was subjected to 1250 steps of first steepest descent minimisation then conjugate gradient minimisation, the latter was carried out with a 0.5 kcal mol -1 Å -2 [55] . The system was then heated from 0K to 300K for 50ps and with a collision frequency of 5.0 ps -1 , using the Langevin dynamics method [56] . Equilibration was then carried out using an NVT ensemble, a periodic boundary was applied and the system maintained at 300K for 50 ps. Production simulation was then carried out for 7 ns with a time step of 1 fs, reference pressure of 1 atm and at 300 K. A cut-off distance for Van der Waals interactions was set at 10 Å and these long range interactions were calculated using the particle mesh Ewald method [57] . Hydrogen convalent bonds were constrained via the SHAKE method [58] .
Analysis of simulations
Simulations were monitored using perl encoded in Amber and resulting graphs produced using GraphPad Prism version 5.03 for Windows (GraphPad Software, San Diego California USA) (Supplementary Figure S1 ). Cluster analysis, secondary structure analysis and RMSF calculations were performed using the ptraj command in Amber 10 and structures visualised using Biovia Discovery Studio. VMD software [59] was used to visualise trajectories, the timeline plugin was used to visualise secondary structure and Normal mode wizard was used to carry out principal component analysis (PCA) both were calculated using 1 ns of equilibrated trajectory, determined by monitoring RMSD over time (Supplementary Figure S2 ) [60] .
Expression and purification of human galactokinase
Recombinant human galactokinase was expressed in, and purified from, Escherichia coli HMS174(DE3) as previously described except that cobalt agarose resin (His-Select, Sigma, Poole, UK) was used in place of nickel agarose [47, 61] . Site-directed mutations were carried out by the QuikChange method [62] and the mutated DNA sequences were verified (GATC Biotech, London, UK).
Variant proteins were expressed and purified using the same protocol as used for the wild-type protein. Purified proteins were stored in buffer A (50 mM Hepes-OH, pH 7.5, 150 mM NaCl, 10%
(v/v) glycerol, 1 mM DTT), frozen at -80 °C in aliquots of 20-100 µl until required.
Steady-state kinetic analysis of galactokinase
Galactokinase activity was measured by coupling the reaction to those catalysed by pyruvate kinase (EC 2.7.1.4) and lactate dehydrogenase (EC 1.1.1.27) [63] . Rates were measured (in triplicate) at 37 °C in 96 well plates by monitoring the decline in absorbance at 340 nm in a Thermo Scientific Multiskan spectrum platereader. The total reaction volume was 160 µl and each reaction contained 50 mM Hepes-OH, pH 7.5, 150 mM NaCl, 5 mM MgCl 2 , 0.4 mM phosphoenolpyruvate, 1mM NADH, 10 %(v/v) glycerol. Reactions were initiated by the addition of enzyme (125-690 nM depending on the variant), monitored for 30 min and the linear portion of the reaction extracted by visual examination. Rates were converted to molar units using the extinction coefficient for NADH (6220 l mol -1 cm -1 [64] ) and a standard curve to correct for the reduced pathlength in the 96 well plate.
Typically reactions were arrayed in a eight by ten grid in which ATP concentration was varied along one axis and galactose along the other [20, 61] . This enabled the extraction of ten datasets with varying ATP concentration and constant galactose concentrations along with eight datasets with varying galactose concentration and constant ATP concentrations. For each of these 18 datasets, rates were plotted against the variable substrate concentration and these data fitted to the Michaelis-Menten equation (1) using non-linear curve fitting as implemented in GraphPad Prism 6.0 (GraphPad Software, CA, USA) [65, 66] : (1) where v is the initial rate, V max,app is the apparent maximal rate, K m,app is the apparent Michaelis constant and [S] is the concentration of the variable substrate. Note that these are apparent kinetic parameters since the experiment was carried out in sub-saturating concentrations of substrates.
Since human galactokinase has an ordered ternary complex mechanism [61] , the steady state constants were estimated by plotting the V max,app values obtained for the various constant concentrations of ATP against these ATP concentrations and fitting these data to equation (2) [67, 68] : (2) where K m,ATP is the Michaelis constant for ATP. A similar process was used to determine K m,gal , the Michaelis constant for galactose.
Analytical methods
Differential scanning fluorimetry (DSF) was used to estimate the thermal unfolding temperature (or "melting" temperature, T m ) essentially as previously described [69] . Galactokinase (6. Protein concentrations were estimated using Bradford's method with BSA as a standard [70] .
Results and Discussion
Previously characterised active site variants have altered MD in key regions
Previous studies have shown that Arg-37 and Asp-186 (and the equivalent residues in galactokinase from other species) are critical to human galactokinase's function. However, this could be due to loss of key functionality in the active site or destabilisation of the protein. To gain further insight into this, we conducted molecular dynamics studies on R37K, R37E, D186N and D186A (variants previously characterised biochemically and shown to have reduced activity [47] ).
All of the active site variants studied showed a propensity for change in two regions adjacent to the active site (residues 174-179 and 231-240). This indicates that these regions are susceptible to change when wild type (WT) human galactokinase is altered at the active site. In WT the 231-240 region occurs primarily as alpha helix (65%) but in R37E, R37K and D186A the region exists for the highest percentage of time as a 3 10 helix (88%, 68% and 50% respectively) and D186N primarily as a turn (90.7%) ( Figure 2a ). All variants show an increase in the presence of a turn in region 174-179 ( Figure 2b ). The proximity of these two regions to the catalytically important residues Glu-174 and Arg-228 is particularly interesting. The distance between Glu-174 and Mg 2+ increases from 4.3 Å in most prevalent WT structure to approximately 6.4 Å in the presence of the turn (in the region 174-179). The distance between Arg-228 and the Mg 2+ increases from 4.8 Å to 5.4 Å when the adjacent region is a turn or decreases to 4.5 Å if the same region is a 3 10 helix (Figure 2c,d) .
These predicted structural and dynamic changes in galactokinase strongly suggest that alteration of either R37 or D186 results in more than changes to active site chemistry. This is consistent with previous data that showed that alteration of these residues resulted in proteins that were less stable to denaturation by urea [47] . The MD simulation also suggests that the two regions identified here may be important in catalysis and for maintaining wild-type structure and dynamics.
Arginine 105 is implicated in ATP binding
Alteration of Arg-105 to methionine reduced the turnover number (k cat ) approximately twofold (Table   1 ; Supplementary Figure S3 ) and increased K m,ATP by approximately the same factor. Consequently, the specificity constant (k cat /K m,ATP ) was also reduced. However, K m,gal was relatively unaffected. This suggests that this residue has a role in the initial interaction between the enzyme and ATP, consistent with the predictions from previous computational studies [49] . The removal of the positive charge at this position has no major changes on the overall, predicted dynamics of the protein (Figure 3 ). DSF indicated no significant alteration of T m (55.4±0.2 °C) compared to WT (55.7±0.3 °C) indicating that stability towards thermal denaturation was not altered by this variation ( Table 2 ; Supplementary Figure S4 ). R105M also showed similar resistance to denaturation by urea to the wild-type (Supplementary Figure S5 ). Arg-105 was previously shown to form an electrostatic interaction with Glu-174 in a molecular dynamics simulation [49] . The simulation of the neutral alteration from arginine to methionine at this position predicted that this variant would cause drifting of all ligands and eventual covalent bonding of Glu-174 to Mg 2+ [49] . MD carried out in this study indicated that region 231-240 has similar structural propensities to WT whereas the presence of a turn between 174-179 increased by 60% (Figure 3a,b ). This was reflected by increased root mean square fluctuation (RMSF) and increased RMSD of normal modes in these two regions (Figure 3c,d) , however increased or decreased flexibility in these two regions does not affect stability of the protein. The MD simulation carried out for this study provided no evidence for an electrostatic interaction between Arg-105 and Glu-174 suggesting the effects on ATP binding are not due to interaction with Glu-174 ( Figure 3e ).
Alteration of arginine 228 impacts on substrate interactions
When Arg-228 was altered to either lysine or methionine there was a modest increase in turnover number and an increase in K m,ATP (Table 1 ; Supplementary Figure S3 ). In the case of R228M, there was a substantial increase in K m,gal , however, the Michaelis constant for this substrate remains essentially unchanged in R228K. Both variants are significantly destabilised compared to the wildtype ( Table 2 ; Supplementary Figure S4 , S5). Similar to the Arg-105 mutants, the presence of the turn from 174-179 showed an increase to around 80% in both Arg228 variants ( Figure 4a ). The region 231-240 is of particular note in R228K where the percentage of time as a turn increases to 93% for residues 233 and 234. However, there is a large increase in the percentage of time, during which the residues 235 and 236 form no secondary structure. This may partly explain to the significant decrease in T m (Figure 4b ; Table 2 ). Another factor which may contribute to the decrease in T m (particularly for R228M) is the increase in flexibility of multiple regions i.e. around residues 100 and 350 ( Figure 4c ).
A negative charge at position 174 is critical for catalysis
Alteration of Glu-174 to aspartate resulted in an enzyme with steady state kinetic parameters very similar to the wild-type ( Table 1 , Supplementary Figure S3 ). However, when the residue was altered to asparagine there was no detectable activity. This suggests that the presence of the negative charge at this position is critical to the function of the enzyme. However, the exact distance of this charge from the backbone is less critical (aspartate has a shorter side chain, compared to glutamate).
E174D was not significantly destabilised compared to the wild-type; however, E174Q became unstable ( Table 2 ; Supplementary Figure S4 , S5).
Despite being very similar to the wild-type, MD simulations of E174D indicated that this alteration introduces α-helix into the region 174-179 ( Figure 5a ). The significant thermal destabilisation of E174Q is not explained by RMSF, which is generally similar to WT enzyme (figure 5c) but may be explained by the loss of structure in the 231-240 region: approximately 99.6% of the time this region formed no defined secondary structure compared to 0% in the WT simulation ( Figure 5b ). Despite alteration in the propensity of secondary structures in the 231-240 and the 174-179 regions and alteration to RMSF per residue, E174D is not significantly different to WT in terms of kinetics or T m which suggests that as long as the 231-240 region remains mostly structured the enzyme is stable.
Conclusions
These data demonstrate the critical role of Glu-174 in catalysis by galactokinase, supporting the predictions made in our previous computational chemistry study. Our findings are consistent with both the active site base and direct attack mechanisms of catalysis. However, they do highlight the fact that active site residues hypothesised to be involved in the active site base mechanism are also required for wild-type protein stability. Therefore, loss of activity on alteration of these residues is insufficient evidence that they are vital for catalysis.
Our findings further highlight the importance of the conformational dynamics of two regions in controlling the activity of this enzyme. This knowledge may be important in the design of novel galactokinase inhibitors and engineered forms of the enzyme with novel specificities. Compounds which induce structural and dynamic transitions similar to those seen in the more unstable forms of the protein are more likely to be successful inhibitors of the enzyme. Manipulation of the dynamics of these regions may result in altered activity or specificity. One previous observation is that increased promiscuity of human galactokinase is generally accompanied by reduced activity [27] .
Ensuring that the structural and dynamic behaviour of these regions remains close to wild-type (perhaps by introducing compensatory changes) may enable the identification of variant enzymes with broad specificity and high activity. Leloir pathway has particular significance in young mammals since the main sugar present in milk is lactose, a disaccharide of glucose and galactose. Reduced activity of any of the enzymes in the Leloir pathway can result in the inherited metabolic disease galactosemia [5] . This disease has a wide spectrum of manifestations ranging from alterations in blood chemistry with only mild effects for the patients to death in childhood [6] . Mutations in the gene encoding galactokinase (GALK1) can result in type II galactosemia in humans and other mammals [7, 8] . This is considered to be the mildest form of galactosemia with early onset cataracts being the most important manifestation. These cataracts can be managed by diet or surgery and there appear to be few long-term complications for the patients [9] . In more severe forms of the disease (types I and III galactosemia) more significant pathology is thought to be linked to the build up of excess galactose 1-phosphate, the product of the reaction catalysed by galactokinase [10, 11] . Therefore, considerable efforts have been made to identify specific inhibitors of galactokinase in order to block the reaction it catalyses [12] [13] [14] [15] [16] [17] . In effect, galactokinase inhibition would convert the more severe forms of galactosemia into the more manageable type II [9] .
Galactokinase has also attracted some interest as a potential biocatalyst [18] . The site-specific modification of monosaccharides is chemically challenging. However, galactokinase targets C 1 -OH for phosphorylation [19] . The high specificity of the human and yeast enzymes towards α-D-galactose (and some closely related sugars) limits their application in the synthesis of a wider range of sugar 1phosphates [19] [20] [21] . Consequently, a number of studies have focussed on identifying galactokinases with broader specificity or broadening the specificity of the enzyme [22] [23] [24] [25] [26] [27] [28] [29] . Many bacterial galactokinases have broader specificity than the human or yeast enzymes [30] . For example, the Escherichia coli enzyme catalyses the phosphorylation of a range of galactose derivatives, but is inactive with D-glucose [26] . Its activity with fluorinated galactose derivatives enabled its use in the enzymatic synthesis of the O-fluoroglucoside of N-methylanthranilate and fluorinated Thomsen-Friedenreich (T) antigens [31, 32] . The promiscuity of the E. coli enzyme has been expanded by protein engineering methods to include a wider range of D-and L-sugars [22, 23, 25] . Galactokinase from Bifidobacterium infantis is active with D-galacturonic acid and can also use a variety of phosphate donors instead of ATP including dATP, GTP, dGTP, ITP and dTTP [33] . This versatility has enabled the use of the enzyme in the synthesis of Galacto-N-biose derivatives [34] . Streptococcus pneumoniae TIGR4 galactokinase is active with D-glucose, some L-monosaccharides and, unusually, with N-acetyl-D-galactosamine [35, 36] . This enzyme has been applied in the synthesis of complex oligosaccharides (e.g. globotriose) and UDP-sugars [37] [38] [39] .
The catalytic mechanism of galactokinase is generally accepted to involve the initial removal of a proton from the C 1 -OH and it is believed that this is done by an aspartate residue acting as a base in the active site [2, 40] . This generates a highly nucleophilic, negatively charged species which attacks the oxygen atom bridging the β-and γ-phosphates of ATP. The γ-phosphate is thus transferred to the galactose molecule and ADP is released. The initial state of the enzyme is regenerated by loss of the proton to water. This mechanism is not universally accepted [41] . Galactokinase is a member of the GHMP kinase family of enzymes (named from some of the enzymes originally assigned to the family:
galactokinase, homoserine kinase, mevalonate kinase and phosphomevalonate kinase) [42, 43] .
Materials and Methods
Molecular dynamics simulations
Analysis of simulations
Expression and purification of human galactokinase
Variant proteins were expressed and purified using the same protocol as used for the wild-type protein.
Purified proteins were stored in buffer A (50 mM Hepes-OH, pH 7.5, 150 mM NaCl, 10%
(v/v) glycerol, 1 mM DTT), frozen at -80 °C in aliquots of 20-100 µl until required. [64] ) and a standard curve to correct for the reduced pathlength in the 96 well plate.
Steady-state kinetic analysis of galactokinase
Typically reactions were arrayed in a eight by ten grid in which ATP concentration was varied along one axis and galactose along the other [20, 61] . This enabled the extraction of ten datasets with varying ATP concentration and constant galactose concentrations along with eight datasets with varying galactose concentration and constant ATP concentrations. For each of these 18 datasets, rates were plotted against the variable substrate concentration and these data fitted to the Michaelis-Menten equation (1) using non-linear curve fitting as implemented in GraphPad Prism 6.0 (GraphPad Software, CA, USA) [65, 66] :
where v is the initial rate, V max,app is the apparent maximal rate, K m,app is the apparent Michaelis constant and [S] is the concentration of the variable substrate. Note that these are apparent kinetic parameters since the experiment was carried out in sub-saturating concentrations of substrates.
Since human galactokinase has an ordered ternary complex mechanism [61] , the steady state constants were estimated by plotting the V max,app values obtained for the various constant concentrations of ATP against these ATP concentrations and fitting these data to equation (2) [67, 68] :
where K m,ATP is the Michaelis constant for ATP. A similar process was used to determine K m,gal , the Michaelis constant for galactose.
Analytical methods
Results and Discussion
Previously characterised active site variants have altered MD in key regions
All of the active site variants studied showed a propensity for change in two regions adjacent to the active site (residues 174-179 and 231-240). This indicates that these regions are susceptible to change when wild type (WT) human galactokinase is altered at the active site. In WT the 231-240 region occurs primarily as alpha helix (65%) but in R37E, R37K and D186A the region exists for the highest percentage of time as a 3 10 helix (88%, 68% and 50% respectively) and D186N primarily as a turn (90.7%) (Figure 2a ). All variants show an increase in the presence of a turn in region 174-179
( Figure 2b ). The proximity of these two regions to the catalytically important residues Glu-174 and Arg-228 is particularly interesting. The distance between Glu-174 and Mg 2+ increases from 4.3 Å in most prevalent WT structure to approximately 6.4 Å in the presence of the turn (in the region 174-179). The distance between Arg-228 and the Mg 2+ increases from 4.8 Å to 5.4 Å when the adjacent region is a turn or decreases to 4.5 Å if the same region is a 3 10 helix (Figure 2c,d) .
Arginine 105 is implicated in ATP binding
Alteration of Arg-105 to methionine reduced the turnover number (k cat ) approximately twofold (Table   1 ; Supplementary Figure S3 ) and increased K m,ATP by approximately the same factor. Consequently, the specificity constant (k cat /K m,ATP ) was also reduced. However, K m,gal was relatively unaffected. This suggests that this residue has a role in the initial interaction between the enzyme and ATP, consistent with the predictions from previous computational studies [49] . The removal of the positive charge at this position has no major changes on the overall, predicted dynamics of the protein (Figure 3 ). DSF indicated no significant alteration of T m (55.4±0.2 °C) compared to WT (55.7±0.3 °C) indicating that stability towards thermal denaturation was not altered by this variation ( Table 2 ; Supplementary   Figure S4 ). R105M also showed similar resistance to denaturation by urea to the wild-type (Supplementary Figure S5 ).
Arg-105 was previously shown to form an electrostatic interaction with Glu-174 in a molecular dynamics simulation [49] . The simulation of the neutral alteration from arginine to methionine at this position predicted that this variant would cause drifting of all ligands and eventual covalent bonding of Glu-174 to Mg 2+ [49] . MD carried out in this study indicated that region 231-240 has similar structural propensities to WT whereas the presence of a turn between 174-179 increased by 60% (Figure 3a,b) . This was reflected by increased root mean square fluctuation (RMSF) and
increased RMSD of normal modes in these two regions (Figure 3c,d) , however increased or decreased flexibility in these two regions does not affect stability of the protein. The MD simulation carried out for this study provided no evidence for an electrostatic interaction between Arg-105 and Glu-174 suggesting the effects on ATP binding are not due to interaction with Glu-174 ( Figure 3e ).
Alteration of arginine 228 impacts on substrate interactions
When Arg-228 was altered to either lysine or methionine there was a modest increase in turnover number and an increase in K m,ATP (Table 1 ; Supplementary Figure S3 ). In the case of R228M, there was a substantial increase in K m,gal , however, the Michaelis constant for this substrate remains essentially unchanged in R228K. Both variants are significantly destabilised compared to the wildtype ( Table 2 ; Supplementary Figure S4 , S5). Similar to the Arg-105 mutants, the presence of the turn from 174-179 showed an increase to around 80% in both Arg228 variants (Figure 4a ). The region 231-240 is of particular note in R228K where the percentage of time as a turn increases to 93% for residues 233 and 234. However, there is a large increase in the percentage of time, during which the residues 235 and 236 form no secondary structure. This may partly explain to the significant decrease in T m (Figure 4b ; Table 2 ). Another factor which may contribute to the decrease in T m (particularly for R228M) is the increase in flexibility of multiple regions i.e. around residues 100 and 350 (Figure 4c ).
A negative charge at position 174 is critical for catalysis
Despite being very similar to the wild-type, MD simulations of E174D indicated that this alteration introduces α-helix into the region 174-179 ( Figure 5a ). The significant thermal destabilisation of E174Q is not explained by RMSF, which is generally similar to WT enzyme (figure 5c) but may be explained by the loss of structure in the 231-240 region: approximately 99.6% of the time this region formed no defined secondary structure compared to 0% in the WT simulation (Figure 5b ). Despite alteration in the propensity of secondary structures in the 231-240 and the 174-179 regions and alteration to RMSF per residue, E174D is not significantly different to WT in terms of kinetics or T m which suggests that as long as the 231-240 region remains mostly structured the enzyme is stable.
Conclusions
Ensuring that the structural and dynamic behaviour of these regions remains close to wild-type (perhaps by introducing compensatory changes) may enable the identification of variant enzymes with broad specificity and high activity. Values are the mean of three determinations and are shown ± the standard errors of these means. One-way ANOVA was used to determine if T m was significantly different from that determined for the wild-type enzyme. ns, not significant (p>0.05); *** significant p<0.01. Figure S3 : Steady state kinetics for wild-type human galactokinase and each of the variants studied here. Points are the mean of three determinations and error bars the standard errors of these means. The lines were obtained by non-linear curve fitting as described in Materials and Methods. Supplementary Fig S3 ( Figure S4 : First derivative of differential scanning flourimetry data for human galactokinase and the variants studied here. Values for T m are reported in Table 2 .
